How the doses are chosen

Every active in every protocol is dosed at the level used in the human trials that studied it — not at the level that fits the capsule count or the price point. Where the trials disagree, we take the lower effective dose and say so on the label.

The rule

• If an active has no controlled human trial behind it, it is not in a protocol.
• If a trial only showed an effect in deficient men, the dose is set to correct the deficiency, not to exceed it.
• If two actives compete for the same pathway, only one goes in.

What that means for you

A trial on a marker is not a promise about your marker. That is why every protocol comes with a baseline panel and a retest instead of a testimonial: the number on your report is the only evidence that counts.